Works by Kelley, Robin K

Results: 23

DAA‐PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy.

Published in:

Journal of Viral Hepatitis, 2025, v. 32, n. 2, p. 1, doi. 10.1111/jvh.14056

By:

Singal, Amit G.;
Reddy, K. Rajender;
Colombo, Massimo;
Morris, Heather L.;
Mospan, Andrea R.;
Cabrera, Roniel;
Kelley, Robin K.;
Kilpatrick, Ryan D.;
Trevisani, Franco;
Farinati, Fabio;
Giannini, Edoardo G.;
Mehta, Neil;
Fried, Michael W.;
Sangro, Bruno

Publication type:

Article

Prognostic and Predictive Markers in Stage II Colon Cancer: Is There a Role for Gene Expression Profiling?

Published in:

Clinical Colorectal Cancer, 2011, v. 10, n. 2, p. 73, doi. 10.1016/j.clcc.2011.03.001

By:

Kelley, Robin K.;
Venook, Alan P.

Publication type:

Article

Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.

Published in:

BMC Cancer, 2015, v. 15, n. 1, p. 206, doi. 10.1186/s12885-015-1195-z

By:

Kelley, Robin K;
Magbanua, Mark Jesus M;
Butler, Timothy M;
Collisson, Eric A;
Hwang, Jimmy;
Sidiropoulos, Nikoletta;
Evason, Kimberley;
McWhirter, Ryan M;
Hameed, Bilal;
Wayne, Elizabeth M;
Yao, Francis Y;
Venook, Alan P;
Park, John W

Publication type:

Article

Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.

Published in:

2015

By:

Kelley, Robin K;
Magbanua, Mark Jesus M;
Butler, Timothy M;
Collisson, Eric A;
Hwang, Jimmy;
Sidiropoulos, Nikoletta;
Evason, Kimberley;
McWhirter, Ryan M;
Hameed, Bilal;
Wayne, Elizabeth M;
Yao, Francis Y;
Venook, Alan P;
Park, John W

Publication type:

journal article

Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series.

Published in:

2019

By:

Kambhampati, Swetha;
Bauer, Kelly E.;
Bracci, Paige M.;
Keenan, Bridget P.;
Behr, Spencer C.;
Gordan, John D.;
Kelley, Robin K.

Publication type:

journal article

A phase I dose-escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC-223 in patients with advanced solid tumors or multiple myeloma.

Published in:

2015

By:

Bendell, Johanna C.;
Kelley, Robin K.;
Shih, Kent C.;
Grabowsky, Jennifer A.;
Bergsland, Emily;
Jones, Suzanne;
Martin, Thomas;
Infante, Jeffrey R.;
Mischel, Paul S.;
Matsutani, Tomoo;
Xu, Shuichan;
Wong, Lilly;
Liu, Yong;
Wu, Xiaoling;
Mortensen, Deborah S.;
Chopra, Rajesh;
Hege, Kristen;
Munster, Pamela N.

Publication type:

journal article

Potent antitumor activity of cabozantinib, a c- MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model.

Published in:

International Journal of Cancer, 2015, v. 136, n. 8, p. 1967, doi. 10.1002/ijc.29225

By:

Song, Eun‐Kee;
Tai, WM;
Messersmith, Wells A.;
Bagby, Stacey;
Purkey, Alicia;
Quackenbush, Kevin S.;
Pitts, Todd M.;
Wang, Guoliang;
Blatchford, Patrick;
Yahn, Rachel;
Kaplan, Jeffrey;
Tan, Aik Choon;
Atreya, Chloe E.;
Eckhardt, Gail;
Kelley, Robin K.;
Venook, Alan;
Kwak, Eunice L.;
Ryan, David;
Arcaroli, John J.

Publication type:

Article

Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma.

Published in:

Liver International, 2019, v. 39, n. 8, p. 1468, doi. 10.1111/liv.14113

By:

Faivre, Sandrine;
Santoro, Armando;
Kelley, Robin K.;
Gane, Ed;
Costentin, Charlotte E.;
Gueorguieva, Ivelina;
Smith, Claire;
Cleverly, Ann;
Lahn, Michael M.;
Raymond, Eric;
Benhadji, Karim A.;
Giannelli, Gianluigi

Publication type:

Article

Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes.

Published in:

2019

By:

Lowery, Maeve A.;
Goff, Laura W.;
Keenan, Bridget P.;
Jordan, Emmet;
Wang, Rui;
Bocobo, Andrea G.;
Chou, Joanne F.;
O'Reilly, Eileen M.;
Harding, James J.;
Kemeny, Nancy;
Capanu, Marianela;
Griffin, Ann C.;
McGuire, Joseph;
Venook, Alan P.;
Abou‐Alfa, Ghassan K.;
Kelley, Robin K.;
Abou-Alfa, Ghassan K

Publication type:

journal article

Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma.

Published in:

Oncologist, 2020, v. 25, n. 12, p. e1825, doi. 10.1634/theoncologist.2020-0521

By:

Harding, James J.;
Kelley, Robin K.;
Tan, Benjamin;
Capanu, Marinela;
Do, Gian Kinh;
Shia, Jinru;
Chou, Joanne F.;
Ferrer, Christine S.;
Boussayoud, Chayma;
Muenkel, Kerri;
Yarmohammadi, Hooman;
El Dika, Imane;
Khalil, Danny N.;
Ruiz, Carmen;
Rodriguez‐Lee, Mariam;
Kuhn, Peter;
Wilton, John;
Iyer, Renuka;
Abou‐Alfa, Ghassan K.

Publication type:

Article

An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM‐080301 in Subjects with Advanced Hepatocellular Carcinoma

Published in:

Oncologist, 2019, v. 24, n. 6, p. 747, doi. 10.1634/theoncologist.2018-0838

By:

El Dika, Imane;
Lim, Ho Yeong;
Yong, Wei Peng;
Lin, Chia‐Chi;
Yoon, Jung‐Hwan;
Modiano, Manuel;
Freilich, Bradley;
Choi, Hye Jin;
Chao, Tsu‐Yi;
Kelley, Robin K.;
Brown, Joanne;
Knox, Jennifer;
Ryoo, Baek‐Yeol;
Yau, Thomas;
Abou‐Alfa, Ghassan K.

Publication type:

Article

Hybrid Capture‐Based Tumor Sequencing and Copy Number Analysis to Confirm Origin of Metachronous Metastases in BRCA1‐Mutant Cholangiocarcinoma Harboring a Novel YWHAZ‐BRAF Fusion.

Published in:

Oncologist, 2018, v. 23, n. 9, p. 998, doi. 10.1634/theoncologist.2017-0645

By:

Lim, Huat C.;
Montesion, Meagan;
Botton, Thomas;
Collisson, Eric A.;
Umetsu, Sarah E.;
Behr, Spencer C.;
Gordan, John D.;
Stephens, Phil J.;
Kelley, Robin K.

Publication type:

Article

Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study.

Published in:

Oncologist, 2017, v. 22, n. 7, p. 804, doi. 10.1634/theoncologist.2016-0415

By:

Golan, Talia;
Raitses‐Gurevich, Maria;
Kelley, Robin K.;
Bocobo, Andrea G.;
Borgida, Ayelet;
Shroff, Rachna T.;
Holter, Spring;
Gallinger, Steven;
Ahn, Daniel H.;
Aderka, Dan;
Apurva, Jain;
Bekaii‐Saab, Tanois;
Friedman, Eitan;
Javle, Milind

Publication type:

Article

Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma.

Published in:

Cancer Medicine, 2021, v. 10, n. 9, p. 3059, doi. 10.1002/cam4.3880

By:

Harding, James J.;
Do, Richard K.;
Yaqubie, Amin;
Cleverly, Ann;
Zhao, Yumin;
Gueorguieva, Ivelina;
Lahn, Michael;
Benhadji, Karim A.;
Kelley, Robin K.;
Abou‐Alfa, Ghassan K.

Publication type:

Article

Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE‐158 and KEYNOTE‐028 studies.

Published in:

International Journal of Cancer, 2020, v. 147, n. 8, p. 2190, doi. 10.1002/ijc.33013

By:

Piha‐Paul, Sarina A.;
Oh, Do‐Youn;
Ueno, Makoto;
Malka, David;
Chung, Hyun Cheol;
Nagrial, Adnan;
Kelley, Robin K.;
Ros, Willeke;
Italiano, Antoine;
Nakagawa, Kazuhiko;
Rugo, Hope S.;
Braud, Filippo;
Varga, Andrea Iolanda;
Hansen, Aaron;
Wang, Hui;
Krishnan, Suba;
Norwood, Kevin G.;
Doi, Toshihiko

Publication type:

Article

Erlotinib in the treatment of advanced pancreatic cancer.

Published in:

Biologics: Targets & Therapy, 2008, v. 2, n. 1, p. 83

By:

Kelley, Robin K.;
Ko, Andrew H.

Publication type:

Article

Genomic profiling of combined hepatocellular‐cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma.

Published in:

Journal of Pathology, 2019, v. 248, n. 2, p. 164, doi. 10.1002/path.5243

By:

Joseph, Nancy M;
Tsokos, Christos G;
Umetsu, Sarah E;
Shain, A Hunter;
Kelley, Robin K;
Onodera, Courtney;
Bowman, Sarah;
Talevich, Eric;
Ferrell, Linda D;
Kakar, Sanjay;
Krings, Gregor

Publication type:

Article

Changes in alpha-fetoprotein across the systemic therapy continuum in advanced hepatocellular carcinoma—a real-world, multicenter study.

Published in:

Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241297085

By:

Li, Michael;
Hannan, Lindsay M.;
Goyal, Lipika;
Bocobo, Andrea G.;
Parks, Anna L.;
Bauer, Kelly;
Baiev, Islam;
Dinicola, Caroline;
Gordan, John D.;
Venook, Alan P.;
Harris, William P.;
Bracci, Paige;
Kelley, Robin K.

Publication type:

Article

Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.

Published in:

PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0222259

By:

Giannelli, Gianluigi;
Santoro, Armando;
Kelley, Robin K.;
Gane, Ed;
Paradis, Valerie;
Cleverly, Ann;
Smith, Claire;
Estrem, Shawn T.;
Man, Michael;
Wang, Shuaicheng;
Lahn, Michael M.;
Raymond, Eric;
Benhadji, Karim A.;
Faivre, Sandrine

Publication type:

Article

Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 372, doi. 10.1159/000529173

By:

Vogel, Arndt;
Kelley, Robin K.;
Johnson, Philip;
Merle, Philippe;
Yau, Thomas;
Kudo, Masatoshi;
Meyer, Tim;
Rimassa, Lorenza

Publication type:

Article

Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling.

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 6, p. 561, doi. 10.1159/000518297

By:

Kelley, Robin K.;
Joseph, Nancy M.;
Nimeiri, Halla S.;
Hwang, Jimmy;
Kulik, Laura M.;
Ngo, Zoe;
Behr, Spencer C.;
Onodera, Courtney;
Zhang, Karen;
Bocobo, Andrea G.;
Benson, Al B.;
Venook, Alan P.;
Gordan, John D.

Publication type:

Article

Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.

Published in:

2021

By:

Giannelli, Gianluigi;
Santoro, Armando;
Kelley, Robin K.;
Gane, Ed;
Paradis, Valerie;
Cleverly, Ann;
Smith, Claire;
Estrem, Shawn T.;
Man, Michael;
Wang, Shuaicheng;
Lahn, Michael M.;
Raymond, Eric;
Benhadji, Karim A.;
Faivre, Sandrine

Publication type:

Correction Notice

Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma.

Published in:

2020

By:

Kelley, Robin K.;
Mollon, Patrick;
Blanc, Jean-Frédéric;
Daniele, Bruno;
Yau, Thomas;
Cheng, Ann-Lii;
Valcheva, Velichka;
Marteau, Florence;
Guerra, Ines;
Abou-Alfa, Ghassan K.

Publication type:

journal article